By expenditures
| Name | Title | Type |
|---|---|---|
| Michael Boulton | Partner | Auditee |
| Daniel O’Brien | Chief Financial Officer | Auditee |
| Michael Boulton | PARTNER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 380037 | 2025 | 2026-01-07 | GREEN HASSON & JANKS LLP | $11.76M |
| 349032 | 2024 | 2025-03-27 | Armanino LLP | $12.35M |
| 317680 | 2023 | 2024-08-21 | Armanino | $10.61M |
| 35806 | 2022 | 2022-12-05 | Armanino LLP | $12.51M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 380037 | 2025 | 2026-01-07 | 1168293 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168292 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168291 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168290 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168289 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168288 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168287 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168286 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168285 | 2025-004 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168284 | 2025-003 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168283 | 2025-003 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168282 | 2025-002 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168281 | 2025-002 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168280 | 2025-002 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168279 | 2025-002 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168278 | 2025-002 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168277 | 2025-002 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168276 | 2025-002 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168275 | 2025-001 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168274 | 2025-001 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168273 | 2025-001 | Material Weakness | Yes | L |
| 380037 | 2025 | 2026-01-07 | 1168272 | 2025-001 | Material Weakness | Yes | L |
| 349032 | 2024 | 2025-03-27 | 1114461 | 2024-004 | Significant Deficiency | - | N |
| 349032 | 2024 | 2025-03-27 | 1114460 | 2024-003 | Significant Deficiency | - | L |
| 349032 | 2024 | 2025-03-27 | 1114459 | 2024-002 | Significant Deficiency | - | L |
| 349032 | 2024 | 2025-03-27 | 1114458 | 2024-001 | Significant Deficiency | - | P |
| 349032 | 2024 | 2025-03-27 | 538019 | 2024-004 | Significant Deficiency | - | N |
| 349032 | 2024 | 2025-03-27 | 538018 | 2024-003 | Significant Deficiency | - | L |
| 349032 | 2024 | 2025-03-27 | 538017 | 2024-002 | Significant Deficiency | - | L |
| 349032 | 2024 | 2025-03-27 | 538016 | 2024-001 | Significant Deficiency | - | P |